Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013

PURPOSE: Human epidermal growth factor receptor 2 (HER2)-positive luminal B type comprises estrogen receptor (ER)-positive and HER2-positive cancers, and HER2-negative luminal B type comprises ER-positive cancers showing a Ki-67 labeling index ≥14% or progesterone receptor (PR) expression of <20%...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Breast Cancer
Autors principals: Ahn, Hyo Jung, Jung, Soo Jin, Kim, Tae Hyun, Oh, Min Kyung, Yoon, Hye-Kyoung
Format: Artigo
Idioma:Inglês
Publicat: Korean Breast Cancer Society 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490264/
https://ncbi.nlm.nih.gov/pubmed/26155291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2015.18.2.149
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars